Market revenue in 2020 | USD 45.5 million |
Market revenue in 2028 | USD 74.8 million |
Growth rate | 6.4% (CAGR from 2020 to 2028) |
Largest segment | Reagent-based |
Fastest growing segment | Reagent-based |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagent-based, Physical Disruption |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Qiagen NV, Danaher Corp, Miltenyi Biotec, IDEX Corp, BD, Claremont BioSolutions, Parr Instrument Company, Covaris, Cell Signaling Technology, Qsonica |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell lysis and disruption market will help companies and investors design strategic landscapes.
Reagent-based was the largest segment with a revenue share of 62.42% in 2020. Horizon Databook has segmented the Mexico cell lysis and disruption market based on reagent-based, physical disruption covering the revenue growth of each sub-segment from 2018 to 2028.
Mexico cell lysis & disruption market is propelled by the growth of biotechnology sector in the country. Nearly 33% of the country’s biotechnology industy works in the human health segment, and 19% in the industrial applications segment.
In addition, most of the leading pharmaceutical manufacturers; such as GlaxoSmithKline, Pfizer, AstraZeneca, Bayer, and Merck; have in-house production facilities in Mexico owing to the geographical convenience and low cost.
In addition, Mexico also offers high-quality standards and has a supportive political framework for biopharmaceutical manufacture. Pharma & biopharma manufacturing is among the top three manufacturing sectors of Mexico in terms of total gross production.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico cell lysis and disruption market , including forecasts for subscribers. This country databook contains high-level insights into Mexico cell lysis and disruption market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account